<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20161022030439N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-01-30</date_registration>
      <primary_sponsor>Gorgan University of Medical Sciences</primary_sponsor>
      <public_title>The influence of Marjoram oil Extract (Origanum Vulgare) in treatment of chronic rhinosinusitis</public_title>
      <acronym>CRS</acronym>
      <scientific_title>Comparative evaluation of the influence of Marjoram oil Extract (Origanum Vulgare) in treatment of chronic rhinosinusitis without nasal polyps with fluticasone spray and sesame oil, concomitant with Life style modification of Traditional Persian Medicine, (a randomized, double-blind, clinical trial)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>1991-01-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>75</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/24181</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: -, Randomization description: Patients will be randomly divided into 3 groups; cases and controls based on Simple Random Allocation (random numbers table), Blinding description: Both the drugs and the placebo are similar in size, shape, color and odor to prevent the bias in participants, clinical care provider and outcome evaluators. And each patient will get an unique code.</study_design>
      <phase>3</phase>
      <hc_freetext>Chronic sinusitis.</hc_freetext>
      <i_freetext>Intervention 1: Prescribed in this group are:1- Marjoram oil nasal spray 2 puffs in each nostril Q12h for 4 wk. 2- Decosalin nasal spray 2 puffs Q12h for 4 wk. 3- Life style modification of Traditional Persian Medicine (LTPM). At the beginning, the Origanum Vulgare from the Gorgan Mountains collected its Voucher Number (1613) and dried. In order to prepare the drug, its semi-weighed was mixed with sesame oil and kept in an incubator at 50 ° C for 72 hours, then passed through the filter and marjoram oil was extracted. In each drop of this extract, equivalent 0.017% of carvacrol is vailable. Life style modification of Traditional Persian Medicine contain: 1- avoiding supination and cool weather contact with the forehead and face 2- nasal irritation and sneezing at the first days of treatment 3- intense physical activities 4- reducing consumptions of some vegetables, such as garlic and onions, as well as date palm during an acute illness phase 5- limiting daily sleep 6- reinforcing the brain by inhaling rose, apple and saffron aromas 7- foot massage. Intervention 2: Prescribed in this group are: 1- Fluticasone nasal spray 2 puffs in each nostril Q12h for 4 wk. 2- Decosalin nasal spray 2 puffs Q12h for 4 wk. 3- Life style modification of Traditional Persian Medicine (LTPM).   Life style modification of Traditional Persian Medicine contain: 1- avoiding supination and cool weather contact with the forehead and face 2- nasal irritation and sneezing at the first days of treatment 3- intense physical activities 4- reducing consumptions of some vegetables, such as garlic and onions, as well as date palm during an acute illness phase 5- limiting daily sleep 6- reinforcing the brain by inhaling rose, apple and saffron aromas 7- foot massage. Intervention 3: Prescribed in this group are: 1- Sesame oil nasal spray (placebo) 2 puffs in each nostril Q12h for 4 wk. 2- Decosalin nasal spray 2 puffs Q12h for 4 wk. 3- Life style modification of Traditional Persian Medicine (LTPM).   Life style modification of Traditional Persian Medicine contain: 1- avoiding supination and cool weather contact with the forehead and face 2- nasal irritation and sneezing at the first days of treatment 3- intense physical activities 4- reducing consumptions of some vegetables, such as garlic and onions, as well as date palm during an acute illness phase 5- limiting daily sleep 6- reinforcing the brain by inhaling rose, apple and saffron aromas 7- foot massage.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Undecided - It is not yet known if there will be a plan to make this available</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyed Abdolreza Kamaneh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 5, The residential complex of Najafinejad, 6th Farhang, 9th Sayyad, Martyr Sayyad shirazi Boulevard</address>
        <city>Gorgan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4917976136</zip>
        <telephone>+98 17 3254 5923</telephone>
        <email>dr.kamaneh@goums.ac.ir</email>
        <affiliation>Gorgan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Marzieh Qaraaty</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 1, The residential complex of Rose, 30th Sayyad, Martyr Sayyad shirazi Boulevard</address>
        <city>Gorgan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4917816337</zip>
        <telephone>+98 17 3254 3614</telephone>
        <email>gharaaty1387@yahoo.com</email>
        <affiliation>Gorgan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: 1- People with chronic sinusitis approved by the Academy of Otolaryngology-Head and Neck Ligation. This criteria contains the typical symptoms of chronic sinusitis, with or without appropriate medical treatment for more than 12 weeks.
2- Positive CT scan which indicates the opacity and swelling of the sinus mucosa.
3- Patients aged 18 to 60 years.
4- Fill the letter of satisfaction by the patient</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Nose and sinus surgery in the last 5 years
Antibiotic or topical corticosteroid use 15 days before entering the study
Using oral corticosteroid 30 days before entering the study
Moderate to severe asthma and mild asthma that has had an acute attack less than 30 days ago
Aspirin- Exacerbated Respiratory Disease
Active infections in the nose and sinuses
Polyps in the nose
Other diseases (neurogenic or psychiatric illness, malignancy, immunodeficiency) in the last 5 years, so that according to researcher, does not have the required qualifications to participate in the clinical trial
Pregnancy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>j32.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Sinusitis (chronic) NOS</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Prescribed in this group are:1- Marjoram oil nasal spray 2 puffs in each nostril Q12h for 4 wk. 2- Decosalin nasal spray 2 puffs Q12h for 4 wk. 3- Life style modification of Traditional Persian Medicine (LTPM). At the beginning, the Origanum Vulgare from the Gorgan Mountains collected its Voucher Number (1613) and dried. In order to prepare the drug, its semi-weighed was mixed with sesame oil and kept in an incubator at 50 ° C for 72 hours, then passed through the filter and marjoram oil was extracted. In each drop of this extract, equivalent 0.017% of carvacrol is vailable. Life style modification of Traditional Persian Medicine contain: 1- avoiding supination and cool weather contact with the forehead and face 2- nasal irritation and sneezing at the first days of treatment 3- intense physical activities 4- reducing consumptions of some vegetables, such as garlic and onions, as well as date palm during an acute illness phase 5- limiting daily sleep 6- reinforcing the brain by inhaling rose, apple and saffron aromas 7- foot massage.</i_keyword>
      <i_keyword>Prescribed in this group are: 1- Fluticasone nasal spray 2 puffs in each nostril Q12h for 4 wk. 2- Decosalin nasal spray 2 puffs Q12h for 4 wk. 3- Life style modification of Traditional Persian Medicine (LTPM).   Life style modification of Traditional Persian Medicine contain: 1- avoiding supination and cool weather contact with the forehead and face 2- nasal irritation and sneezing at the first days of treatment 3- intense physical activities 4- reducing consumptions of some vegetables, such as garlic and onions, as well as date palm during an acute illness phase 5- limiting daily sleep 6- reinforcing the brain by inhaling rose, apple and saffron aromas 7- foot massage.</i_keyword>
      <i_keyword>Prescribed in this group are: 1- Sesame oil nasal spray (placebo) 2 puffs in each nostril Q12h for 4 wk. 2- Decosalin nasal spray 2 puffs Q12h for 4 wk. 3- Life style modification of Traditional Persian Medicine (LTPM).   Life style modification of Traditional Persian Medicine contain: 1- avoiding supination and cool weather contact with the forehead and face 2- nasal irritation and sneezing at the first days of treatment 3- intense physical activities 4- reducing consumptions of some vegetables, such as garlic and onions, as well as date palm during an acute illness phase 5- limiting daily sleep 6- reinforcing the brain by inhaling rose, apple and saffron aromas 7- foot massage.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Cough. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Posterior nasal discharge. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Need to blow nose. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Sneezing. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Runny nose. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Nasal obstruction. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Loss of smell or taste. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Thick nasal discharge. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Post-nasal discharge. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Ear fullness. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Dizziness. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Ear pain. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Facial pain/pressure. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Difficulty falling asleep. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Waking up at night. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Lack of a good night’s sleep. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Waking up tired. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Exhausted feeling during day. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Reduced productivity. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Reduce concentration. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Frustration or irritability. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Sad. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
      <prim_outcome>Embarrassed. Timepoint: Before and the end of the intervention. Method of measurement: SNOTE22 questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Gorgan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-01-17</approval_date>
        <contact_name>Ethics committee of Golestan Univercity of Medical Sciences</contact_name>
        <contact_address>Phalsaphy complex, Shast kola Road Gorgan Golestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
